The Sanford Guide to Antimicrobial Therapy 2022 (Spiral Edition)

About this book

The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organizations antimicrobial stewardship program The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians pharmacists physician assistants nurse practitioners and other clinicians. Coverage includes: Clinical syndromes (pathogens bacterial fungal mycobacterial parasitic viral) Anti-infective agents (dosing pediatric adjustments renal adjustments adverse effects activity pharmacology drug-drug interactions) Preventative therapy. Whats new in 2022: Numerous changes throughout with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs cefiderocol ibrexafungerp brincidofovir cabotegravir doravirine and more. New Tables - ECMO Drug Dosing Adjustment (Table 10F) and QTc Prolongation (Table 10G). Table 1: Initial Choice of Antimicrobial Therapy - Numerous changes including 2021 CDC STI updates recommendations for resistant infections. Table 5: Recommendations for MDR Bacteria - Updates for gram-negative bacilli updated based on recent evidence and IDSA Guidelines. Table 12: Treatment of Mycobacterial Infections - Revised recommendations for latent M. tuberculosis & non-tuberculous mycobacteria. Table 13: Treatment of Parasitic Infections - Significant changes to amebic meningoencephalitis babesiosis and trypanosomiasis and updates to sources for antiparasitic drugs (Table 13D). Table 14 - Updates to COVID recommendations (see digital content for latest information).